Connect your AI

Adaptive Biotechnologies ADPT Inventories

Inventories at other companies

Guardant HealthGH

$83.85M+8.5%

Natera, Inc.NTRA

$70.72M+40.4%

GeneDx HoldingsWGS

$12.24M-3.3%

DanaherDHR

$2.61B+3.0%

Charles River LaboratoriesCRL

$359.72M+24.0%

RevvityRVTY

$387.51M+1.6%

Other financials

Income statement

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Adaptive Biotechnologies's inventories?: Adaptive Biotechnologies (ADPT) reported inventories of $11.21M in Q1 2026.
How has Adaptive Biotechnologies's inventories changed year-over-year?: Adaptive Biotechnologies's inventories increased by 29.0% year-over-year, from $8.68M to $11.21M.
What is the long-term trend for Adaptive Biotechnologies's inventories?: Over 5 years (2020 to 2025), Adaptive Biotechnologies's inventories has grown at a -6.9% compound annual growth rate (CAGR), from $14.06M to $9.82M.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.